The Science of Skin

Epizódok

• The Evolution of Fractionated Lasers: Fraxel, FTX & Clear + Brilliant with Dr. Rishi Chopra 07.07.2026 26p

  🎧 In this episode of the Science of Skin Podcast, host Dr. Patty Farris sits down with Dr. Rishi Chopra — a Harvard-trained, fellowship-trained cosmetic dermatologist from the Mass General Wellman Center for Photomedicine — for a deep dive into the evolution of fractionated laser resurfacing. Dr. Chopra breaks down how fractional photothermolysis, first described by Drs. Rox Anderson and Dieter Manstein in 2004, transformed dermatology by moving away from painful, high-downtime ablative resurfacing toward safer, more effective treatments. He walks through the progression from the original Fraxel Restore to the Fraxel Dual and the newly launched Fraxel FTX, explaining the science behind each wavelength (1550nm, 1927nm) and how these advances made treatments more tolerable, more precise, and safer for patients with skin of color. The conversation also covers a remarkable patient case: a young man with severe acne scarring who saw nearly 100% improvement after six Fraxel FTX treatments — illustrating just how far this technology has come. Dr. Chopra then discusses the Clear + Brilliant Touch, a lower-downtime "lunchtime facial" option that's especially popular with younger patients and serves as both an entry point and a maintenance tool for building long-term patient trust. Whether you're a dermatology professional refining your device menu or simply curious about the science behind modern laser resurfacing, this episode offers a comprehensive, practical look at how far fractionated laser technology has come — and where it's headed next. In this episode: The history of ablative vs. fractionated laser resurfacing Fraxel Restore → Dual → FTX: what changed and why Treating acne scars and photoaging safely in skin of color A dramatic real-world patient case study Clear + Brilliant Touch as a "lunchtime facial" option Building patient trust through a tiered treatment approach This episode is sponsored by Solta Medical. Dr. Chopra has been compensated by Solta Medical for his participation. Full prescribing and safety information for Fraxel and Clear + Brilliant laser systems is available at www.fraxel.com/HCP and www.clearandbrilliant.com/HCP.See omnystudio.com/listener for privacy information.
• Roflumilast Cream for Toddler Eczema, Psoriasis & Seborrheic Dermatitis 30.06.2026 21p

  Dr. Ted Lain sits down with board-certified pediatric dermatologist Dr. Nnenna Agim to discuss the toddler indication for roflumilast cream (Zoryve) and how non-steroidal topicals are changing the treatment landscape for atopic dermatitis, psoriasis, and seborrheic dermatitis in children. In this episode of the Science of Skin Podcast, Dr. Agim shares her real-world clinical experience using roflumilast cream 0.05% (ages 2-5) and 0.15% (ages 6+) as a steroid-sparing alternative for pediatric eczema, explaining why more families are requesting non-steroidal options from the start of treatment. The conversation covers: Why roflumilast (Zoryve) is safe to use on any body surface, including the face and skin folds Managing parent expectations and proper dosing to avoid overuse The importance of pairing roflumilast with ceramide-rich, fragrance-free moisturizers like CeraVe, La Roche-Posay, and Vaseline How roflumilast compares to crisaborole (Eucrisa) and topical corticosteroids in tolerability Treating psoriasis and seborrheic dermatitis in children with roflumilast foam and cream Skin barrier repair, ceramide production, and the role of the acid mantle in atopic dermatitis Caring for textured hair and scalp conditions in pediatric patients Real patient outcomes and quality-of-life improvements with Zoryve This episode is sponsored by Arcutis Biotherapeutics and is part of an ongoing series exploring roflumilast formulation science. Don't miss the related episode on roflumilast's formulation with Dr. Chris Bunick. Learn more about the Science of Skin Summit (Austin, TX) and the new Science of Skin Longevity Summit (Scottsdale, AZ, Feb 2027) at scienceofskinsummit.com. 🔔 Subscribe and leave a 5-star rating to support the show! Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Hair Loss Treatments: Dr. Nicole Rogers on What Actually Works 23.06.2026 32p

  In this episode of the Science of Skin podcast, board-certified dermatologist Dr. Patti Farris sits down with Golden Follicle Award winner and hair restoration surgery pioneer Dr. Nicole Rogers to break down everything you need to know about hair loss treatment — from trending social media remedies to cutting-edge clinical trials. Whether you're experiencing male pattern baldness, female pattern hair loss, postpartum shedding, or hair thinning from GLP-1 weight loss drugs, this episode covers it all. Dr. Rogers shares her expert framework for building a personalized hair loss treatment plan and explains exactly when to move from over-the-counter solutions to prescription therapies. Topics covered include: Rosemary oil, pumpkin seed oil & nutraceuticals — do they actually work? Oral minoxidil vs. topical minoxidil — what the latest research shows Extended-release oral minoxidil (Veridermix) — the next FDA-approved hair loss drug? Finasteride and dutasteride for men and women — dosing, safety, and the truth about post-finasteride syndrome Spironolactone for pre-menopausal women with hair loss Topical finasteride and dutasteride via compounding pharmacy Low-level laser/red light therapy (LLLT) for hair growth — what the science really says PRP (platelet-rich plasma) injections — when they help and when they're overhyped Exosomes for hair loss — promise vs. FDA concerns PP405 and stem cell activation — the groundbreaking new molecule in clinical trials FUE vs. FUT hair transplant surgery — what's right for you No-shave FUE — the emerging frontier in hair restoration Hair transplants for women — why strip harvesting remains the gold standard If you're searching for answers on androgenetic alopecia, alopecia areata, telogen effluvium, scalp health, DHT blockers, hair regrowth treatments, or the best dermatologist-recommended solutions for thinning hair, this is the episode you've been waiting for. Dr. Rogers brings decades of clinical expertise, peer-reviewed research, and real patient outcomes to help you navigate the overwhelming world of hair loss — with science, not social media hype. 🎙️ Subscribe, leave a review, and share with anyone on their hair loss journey. New episodes available on Apple Podcasts and Spotify. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Clinical Trials in Dermatology: Insider Tips from Top Researchers 16.06.2026 28p

  Are you a dermatologist curious about clinical research — or a seasoned trialist looking to reignite your passion? In this episode of the Science of Skin Podcast, Dr. Ted Lane (Austin, TX) sits down with Dr. Jason Hawkes, Chief Scientific Officer at Oregon Medical Research Center, to pull back the curtain on what it really means to build a career in dermatology clinical trials. From navigating the growing complexity of modern trial protocols to reframing the pharma-physician relationship, Ted and Jason share candid insights that only experienced clinical trialists can offer. They discuss how running trials makes you a sharper diagnostician, why medical dermatology remains one of the most rewarding specialties, and how industry partnerships open unexpected academic and commercial doors. You'll also hear their honest takes on mentorship — including the must-read JAMA article Mentorship Malpractice — and why thinking of your career as a lattice, not a ladder may be the most liberating shift you can make. Whether you're five years into practice or just starting out, this episode is packed with hard-won wisdom on building a meaningful, intellectually stimulating career in dermatology. 📩 Questions or future episode ideas? Email: questions@scienceofskinpodcast.com Topics Covered: How clinical trials combat physician burnout The real motivations behind patient participation in trials How to interpret clinical data like a trialist Navigating the evolving complexity of trial conduct Building industry relationships the right way The importance of mentorship in dermatology research Career advice: "lattice, not a ladder" Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Roflumilast vs. Crisaborole: The PDE4 Science That Changes Everything 09.06.2026 26p

  What really separates roflumilast (Zoryve) from other PDE4 inhibitors — and why does it matter for your patients with atopic dermatitis, psoriasis, or seborrheic dermatitis? In this episode, Dr. Ted Lane sits down with Dr. Chris Bunick, Associate Professor of Dermatology at Yale School of Medicine and Editor-in-Chief of Dermatology Times, for a deep dive into the biochemistry, formulation science, and clinical implications behind this breakthrough topical treatment. In this episode, you'll learn: Why roflumilast binds PDE4 with 200x more potency than apremilast — and 1,000x more than crisaborole How cyclic AMP inhibition controls upstream cytokine pathways (TH1, TH2, TH17) across multiple inflammatory skin diseases The science behind the Crotofos emulsifier — and why the right emulsifier protects the skin barrier instead of stripping ceramides Why formulating at pH 5.5 matters for filaggrin, keratin, and barrier integrity How the roflumilast foam is specifically engineered for scalp conditions and hair-bearing areas What's next in topical formulation innovation — from targeted dermal delivery to longevity skincare Whether you're a dermatologist, resident, PA, NP, or skincare enthusiast who wants to understand the why behind cutting-edge topicals, this episode is packed with clinical and scientific insight you won't find anywhere else. 🎙️ This episode is sponsored by Arcutis Biotherapeutics, maker of roflumilast cream and foam. 📧 Send your questions to: questions@scienceofskinnsummit.com 📅 Science of Skin Summit — September 19–21, Austin, TX 📅 Longevity Meeting — February 19 - 21, Scottsdale, AZ Subscribe, leave a 5-star review, and follow Dr. Bunick's podcast: ABCDs in Dermatology. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• NP & PA Dermatology Track Debuts at Science of Skin Summit 02.06.2026 15p

  Big news for nurse practitioners and physician assistants in dermatology! Dr. Patti Farris is joined by PA and dermatology leader Kristin Rygg to announce a brand-new NP/PA track at the 2026 Science of Skin Summit — a first-of-its-kind opportunity for advanced practice providers to learn alongside their physician colleagues. In this episode, you'll hear: Why this NP/PA-dedicated track was created and what makes it different A full breakdown of the September 10th agenda — from immunology and inflammatory skin disease to biologics, GLP-1s, and advanced skincare ingredients How the curriculum is designed for every career stage, from new grads to seasoned practitioners What to expect at the full Summit (September 17–20, 2026), including case-based learning, product theaters, and a longevity track How NPs and PAs will be featured on the main stage for the first time Whether you're a PA, NP, dermatologist, or practice owner, this episode is your inside look at a summit built for collaboration, clinical excellence, and professional growth. 🔗 Register now at scienceofskinsummit.com 🔔 Subscribe to Science of Skin and leave a review — it helps us bring more cutting-edge dermatology science straight to you. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Your Skin Has a Clock: Circadian Rhythms, Aging & Chrono Skincare 26.05.2026 25p

  Did you know your skin has its own internal clock — and that ignoring it could be accelerating aging? In this episode of the Science of Skin podcast, board-certified dermatologist Dr. Patti Farris sits down with renowned cosmetic dermatologist and Harvard graduate Dr. Ava Shamban — founder of AvaMD Dermatology and the skincare line Althea — to break down the fascinating science of circadian rhythms and skin health. They cover: What circadian rhythms actually are and why every skin cell has its own biological clock How clock genes control 50% of your genome — and drive collagen production, DNA repair, and barrier function Why screen time, blue light, and night-shift schedules are silently destroying your skin The emerging field of chrono cosmetics — syncing your skincare routine to your skin's natural 24-hour cycle Dr. Ava's science-backed skincare line Althea and its groundbreaking day/night formulations Her new multimodal at-home device featuring LED therapy, radio frequency, and microcurrent — pending FDA clearance Whether you're a skincare enthusiast or a medical professional, this episode will completely change how you think about anti-aging, skin longevity, and your nighttime skincare routine. 🔔 Subscribe to Science of Skin and leave a review — it helps us bring more cutting-edge dermatology science straight to you. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Skin Longevity, HRT & Anti-Aging Science with Dr. Hillary Lin 19.05.2026 31p

  What does longevity medicine have to do with your skin? Everything, according to Dr. Hillary Lin — Stanford-trained internist, longevity expert, and founder of CareCorps. In this episode of the Science of Skin podcast, Dr. Patti Farris sits down with Dr. Lin to explore the powerful connection between systemic health and skin aging. Together they break down the science behind cellular senescence, oxidative stress, and the hallmarks of aging — and what they mean for your skin from the inside out. They cut through the noise on trending anti-aging supplements like rapamycin, NAD precursors, urolithin A, peptides, and creatine, separating evidence-backed strategies from longevity washing. Dr. Lin also shares her expert take on hormone replacement therapy (HRT) and estrogen's critical role in collagen production, skin hydration, and elasticity during perimenopause and menopause. Whether you're a skincare professional or a health-conscious consumer, this episode delivers practical, science-first insights on skin longevity, metabolic health, and how to build a longevity protocol that actually works. Topics covered: skin aging, longevity medicine, HRT, perimenopause, collagen, cellular senescence, rapamycin, NAD, creatine, peptides, anti-aging supplements, menopause skin care, hormonal health, longevity washing To watch this and other episodes, be sure to check out our YouTube page  DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• GLP-1s in Dermatology: Tirzepatide, Semaglutide & Retatrutide for Psoriasis & Metabolic Skin Disease 12.05.2026 29p

  Could GLP-1 medications be the missing piece in treating inflammatory skin disease? In this episode of Science is Skin, Dr. Ted Lain sits down with Dr. Lindsey Bordone — former Columbia University associate professor of dermatology, now in private practice at Bordone Dermatology in Scottsdale, Arizona — for a deep dive into metabolic disease and the skin. Dr. Bordone was among the first dermatologists to prescribe GLP-1 agonists for her patients, and in this conversation she explains exactly why. From the link between hyperinsulinemia and chronic inflammation to the visible skin signs of insulin resistance — skin tags, acanthosis nigricans, forearm hair loss — she makes the case that dermatologists are uniquely positioned to catch metabolic disease before any other specialty. Dr. Bordone walks through how she uses tirzepatide (Mounjaro/Zepbound), semaglutide (Ozempic/Wegovy), and the emerging triple-G drug retatrutide, including her lab protocols, dosing philosophy, how to manage GI side effects, and the surprising interaction between GLP-1s and estrogen therapy. In this episode: Why high BMI reduces biologic efficacy in psoriasis patients How to check fasting insulin (HOMA-IR) and why most physicians aren't doing it Skin signs of insulin resistance: skin tags, forearm hair loss, and neck skin thickening Tirzepatide vs. semaglutide vs. retatrutide — how to choose and when Retatrutide's remarkable 93% fatty liver clearance rate in clinical trials The truth about sarcopenia and muscle loss on GLP-1 medications Dosing protocols, side effect management, and when NOT to escalate quickly Protein intake recommendations during active weight loss Estrogen and GLP-1 synergy — what dermatologists need to know Lab work to run before and during GLP-1 therapy How to build an insurance case for continued medication coverage Resources mentioned: HOMA-IR fasting insulin/glucose testing AAD resources on metabolic dermatology Bordone Dermatology — Scottsdale, Arizona Enjoyed this episode? Share it with a colleague and leave us a five-star review. Subscribe so you never miss an episode of Science is Skin. To watch this and other episodes, be sure to check out our YouTube page  DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Skin Signs of Human Trafficking & the Science of Longevity 05.05.2026 28p

  What do tattoos, trafficking survivors, and longevity medicine have in common? More than you'd think. In this episode of Science is Skin, board-certified dermatologist Dr. Ted Lain sits down with Dr. Shadi Kourosh — Harvard Medical School professor, public health physician, and director of dermatology at Nantucket Cottage Hospital — for a conversation that spans medicine, advocacy, and cutting-edge science. Dr. Kourosh shares how her work with underserved communities at Massachusetts General Hospital led her to the frontlines of the fight against human trafficking. She breaks down the "Three I's" — infections, injuries, and imagery — the clinical signs dermatologists and healthcare providers should recognize when a patient may be a trafficking victim. She also discusses trauma-informed care, how to create a safe environment for disclosure, and the STEER app (Skin Signs of Trafficking Education Advocacy and Resources), a free tool designed to connect providers and survivors with local resources. In the second half, Dr. Kourosh pivots to longevity medicine — one of dermatology's fastest-growing frontiers — and explains why separating skin science from snake oil has never been more important for patient protection and consumer health. In this episode: How dermatologists can identify skin signs of human trafficking The Three I's framework: infections, injuries, and imagery in trafficking tattoos Trauma-informed care and the "warm handoff" approach for at-risk patients The STEER app and AAD Human Trafficking Toolkit — free resources for providers Laser tattoo removal as a pathway to safety and reintegration for survivors The new science of skin longevity and preventive dermatology Fact vs. fiction in the longevity medicine space Resources mentioned: STEER App (Skin Signs of Trafficking, Education, Advocacy & Resources) AAD Human Trafficking Toolkit: aad.org American Society for Laser Medicine and Surgery (ASLMS) Polaris Project National Human Trafficking Hotline To watch this and other episodes, be sure to check out our YouTube page  DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Skin Science Breakthroughs: Vitamin C Serums, Scalp Health, SPF 100 & the Future of Anti-Aging Skincare — Live from AAD 2024 28.04.2026 15p

  Science of Skin Podcast · Sponsored by Neutrogena · Recorded live at the American Academy of Dermatology, Denver Dermatologists Dr. Patti Farris and Dr. Ted Lain go live from the American Academy of Dermatology (AAD) in Denver to break down the latest skincare innovations from Neutrogena. In this episode, the hosts dive deep into three cutting-edge products: the Neutrogena Collagen Bank 15% Vitamin C Serum featuring pure L-ascorbic acid, 2% polyhydroxy acid (gluconolactone), and the award-winning microdipeptide (diacetyl dipeptide); the new Hair Restore Scalp Serum, which brings the microdipeptide alongside minoxidil (Rogaine), niacinamide, panthenol, caffeine, feverfew, centella asiatica, and arginine for a comprehensive approach to scalp health and hair loss prevention; and Neutrogena's Ultra Sheer SPF 100 sunscreen with Helioplex technology and antioxidant blends designed to protect against UVB, long-wave UVA, and high-energy visible (HEV) blue light. The doctors explore why L-ascorbic acid is the gold-standard form of vitamin C, how peptides are having a moment in dermatology, the skinification of the scalp, the risks of lipid peroxidation and post-acne hyperpigmentation, and why high SPF formulations matter even beyond UVB protection. Whether you're a dermatologist building patient regimens or a skincare enthusiast looking for science-backed product recommendations, this episode is packed with clinical insight and practical guidance. To watch this and other episodes, be sure to check out our YouTube page  DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Treating Advanced Skin Cancer Without Surgery: Hedgehog & PD-1 Inhibitors with Dr. Todd Schlesinger 21.04.2026 31p

  In this clinically rich episode, host Dr. Ted Lain sits down with board-certified dermatologist and global skin cancer expert Dr. Todd Schlesinger — AAD Board of Directors member, Mohs surgeon, clinical assistant professor at George Washington University School of Medicine, and medical director of the Clinical Research Center of the Carolinas — for a deep dive into systemic and targeted therapies for non-melanoma skin cancer (NMSC). The doctors begin with a thorough breakdown of the hedgehog signaling pathway (PATCHED, Smoothened, GLI-1 transcription) and how mutations in this pathway drive basal cell carcinoma (BCC) growth. They compare the two FDA-approved hedgehog pathway inhibitors (HHIs) — vismodegib (Erivedge) and sonidegib (Odomzo) — covering their mechanisms of action, volume of distribution differences (16–18L vs. ~9,000L), indications for locally advanced and metastatic BCC, how to define "locally advanced," and complete vs. partial response rates. Dosing strategies are addressed in detail, including alternate-day dosing and treatment breaks backed by the MIKIE study and STEVIE safety study. For managing the most common adverse events — muscle cramps, dysgeusia, weight loss, and fatigue — Dr. Schlesinger shares his clinical protocol using L-carnitine supplementation (1,500–2,000mg liquid, started 2–4 weeks before therapy) along with calcium and CoQ10. The conversation then moves to PD-1 and PD-L1 checkpoint inhibitors for locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC) and BCC, covering cemiplimab (Libtayo), pembrolizumab (Keytruda), and nivolumab (Opdivo). The hosts explain the immune checkpoint mechanism using a memorable analogy, discuss how UV exposure upregulates PD-1 on tumor cells, and explore the practical realities of dermatologists prescribing infusion-based immunotherapy — including multidisciplinary care team logistics, buy-and-bill considerations, and when to partner with oncology. The episode closes with an exciting look at the pipeline: intralesional therapies for nodular and superficial BCC from companies including Verica, iViva, PHIO, and Feldan, red light PDT for superficial BCC nearing FDA approval, and the broader question of where these drugs fit as neoadjuvant, adjuvant, or primary therapies — and what complete response benchmarks (80–95%) dermatologists should expect before adopting non-surgical primary options. To watch this and other episodes, be sure to check out our YouTube page  DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• The Science Behind Neutrogena Evenly Clear: Acne Treatments That Go Beyond the Breakout 14.04.2026 17p

  Acne doesn't end when the breakout does — and this episode is all about treating the full journey. In this special Neutrogena-sponsored episode of the Science of Skin podcast, board-certified dermatologists Dr. Ted Lain and Dr. Patti Farris sit down with Rabab Hussain, PharmD, RPh. from Neutrogena's Translational Science team to break down the brand-new Evenly Clear acne line — a dermatologist-informed collection designed to tackle both active acne and post-inflammatory hyperpigmentation (PIH) in one cohesive regimen. Together, they dive deep into the science behind each product, including: Evenly Clear Acne Cleanser — 2% salicylic acid + polyhydroxy acid (PHA/gluconolactone) for barrier-respecting exfoliation Evenly Clear Acne Gel Moisturizer — 0.5% salicylic acid, N-acetylglucosamine, and a pre & postbiotic complex to support the skin microbiome and fade post-acne marks Evenly Clear Acne Cleansing Mask — 3.5% benzoyl peroxide + bentonite clay for oily, acne-prone skin on the face and body Evenly Clear Retinoid — 0.1% adapalene for acne treatment, exfoliation, and anti-pigmentation benefits Evenly Clear Acne Exfoliant — an AHA + BHA + PHA trifecta with glycolic acid, salicylic acid, mandelic acid, and PHA for multi-acid exfoliation with tolerability in mind Evenly Clear Clarifying Spray — a stabilized hypochlorous acid spray for on-the-go skin support Whether you're treating teens, adult women with hormonal acne, or patients with skin of color concerned about dark marks, this episode gives you the clinical rationale to confidently recommend OTC options — no prior authorization required. Topics covered: acne treatment regimens, post-inflammatory hyperpigmentation, skin barrier repair, the skin microbiome and dysbiosis, retinoids OTC, chemical exfoliants, hypochlorous acid, benzoyl peroxide tolerability, and building a complete acne skincare routine. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.  See omnystudio.com/listener for privacy information.
• The Future of Skin Longevity: Pro-Aging, Cosmeceuticals & the Science Redefining Dermatology 09.04.2026 10p

  The skincare conversation is shifting — and dermatology is leading the charge. In this episode, we dive deep into the emerging world of skin longevity, exploring why the industry is moving away from "anti-aging" and embracing a bold new pro-aging philosophy that celebrates long-term skin health over surface-level fixes. We break down what the groundbreaking Science of Skin Longevity Summit means for dermatologists, skincare professionals, and consumers alike — and why the skin is being recognized as the body's hallmark longevity organ. From longevity cosmeceuticals and cutting-edge procedures like microneedling and dermal fillers, to the complex, personalized science of measuring skin health over time, this episode covers it all. We also explore how artificial intelligence is poised to revolutionize personalized longevity skincare, and why collaboration between dermatologists and the cosmetic industry is no longer optional — it's essential. Whether you're a skincare enthusiast, a medical professional, or simply someone who wants to age with intention, this episode will change the way you think about your skin — for life. In this episode, you'll learn: Why "pro-aging" is replacing "anti-aging" in modern dermatology What skin longevity actually means — and how to measure it How cosmeceuticals are evolving to support long-term skin health Where microneedling, fillers & regenerative procedures fit into a longevity-focused practice How AI will personalize your skincare and longevity journey 🌐 For more information, visit: scienceofskinsummit.com/longevity DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Beyond Steroids: PDE4 Inhibitors & the Future of Topical Dermatology with Dr. Peter Lio 31.03.2026 31p

  In this episode of the Science of Skin Podcast, board-certified dermatologist Dr. Ted Lain sits down with world-renowned eczema and atopic dermatitis expert Dr. Peter Lio, founder of the Chicago Integrative Eczema Center, to unpack a game-changing shift in how dermatologists think about chronic inflammatory skin conditions. If you're a dermatologist, skincare professional, or someone managing eczema, psoriasis, seborrheic dermatitis, or other steroid-responsive skin conditions — this episode is essential listening. What you'll learn: Why topical corticosteroids, despite being effective, carry real risks with long-term use — including skin atrophy, growth suppression in children, HPA axis suppression, and the increasingly recognized phenomenon of topical steroid withdrawal (TSW) What PDE4 (phosphodiesterase 4) is, how it drives the inflammatory cascade in atopic dermatitis, and why targeting it is a "Goldilocks" approach to treatment The evolution of PDE4 inhibitor topical therapies, including roflumilast (Zoryve) — its origins as an oral COPD drug and its transformation into a highly effective topical for eczema, psoriasis, and seborrheic dermatitis The concept of "PDE4 inhibitor-responsive dermatoses" — a new framework introduced in Dr. Lio's JAAD publication that expands the clinical use of this drug class across a wide range of skin conditions, including rare and pediatric diseases with zero FDA-approved treatments The excellent safety profile of topical roflumilast, including what side effects to watch for and how to counsel patients Why dermatologists must continue championing innovation in topical therapies — not just biologics — to serve patients with mild-to-moderate disease Featured guest: Dr. Peter Lio, MD — Clinical Assistant Professor of Dermatology and Pediatrics, Northwestern University; Founder, Chicago Integrative Eczema Center; Global speaker, researcher, and consultant in atopic dermatitis and inflammatory skin disease. Sponsored by Arcutis Biotherapeutics, makers of roflumilast (Zoryve) topical foam and cream. This episode was recorded ahead of the 2026 AAD Annual Meeting. Link to Dr. Lio's JAAD publication on PDE4 inhibitor-responsive dermatoses. DISCLAIMER:  This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment  See omnystudio.com/listener for privacy information.
• Hidradenitis Suppurativa Treatment, Biologics & Breakthroughs 31.03.2026 33p

  What is Hidradenitis Suppurativa (HS), and how is it treated? In this episode of the Science of Skin podcast, dermatologist Dr. Ted Lain is joined by HS specialist Dr. Steve Daveluy to break down everything you need to know about this chronic inflammatory skin disease — from early diagnosis to cutting-edge treatments. In this episode, we cover: What is Hidradenitis Suppurativa (HS) and who does it affect? Why pain is the #1 reason HS patients seek medical care How shame and stigma impact HS patients — and why HS is never the patient's fault Early HS treatment options: antimicrobial washes, topical antibiotics, and more The role of biologics in managing moderate-to-severe HS Emerging HS treatments: JAK inhibitors, nanobodies, and drugs in the pipeline Understanding HS pathogenesis and the immune pathways involved Why a multifactorial, personalized treatment approach is essential for HS management Whether you're a dermatologist, healthcare provider, or someone personally affected by Hidradenitis Suppurativa, this episode offers expert insight into the latest research, treatment strategies, and the future of HS care. 🎙️ Subscribe to the Science of Skin podcast for the latest in dermatology, skincare science, and clinical breakthroughs. DISCLAIMER:  This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Leading From the Front: AAD President Dr. Susan Taylor on Advocacy, Women in Medicine & the Future of Dermatology 24.03.2026 18p

  What does it take to lead the most powerful dermatology organization in the world? In this inspiring episode of The Science of Skin podcast, host Dr. Patti Farris sits down with outgoing American Academy of Dermatology (AAD) President Dr. Susan Taylor for a candid look at her landmark year at the helm.  Dr. Taylor shares how she fought for Medicare physician payment reform on Capitol Hill, tackled scope of practice battles across the country, and launched the widely successful "Your Dermatologist Knows" public education campaign — all while championing women in medicine and leadership.  She also gets personal about the invisible "second shift" burden professional women carry at home and why delegation is leadership — a mindset that is transforming the lives of physicians everywhere.  From AI in dermatology to unifying a diverse specialty, Dr. Taylor offers a powerful and practical vision for the future of skin care and medicine.  A must-listen for dermatologists, medical professionals, and anyone passionate about skin health, advocacy, and breaking barriers in medicine. DISCLAIMER:  This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Skincare as a Clinical Strategy: Exosomes, Hair Restoration & the Future of Aesthetic Dermatology 17.03.2026 28p

  What does it really take to build a skincare-forward aesthetic practice — and why does it matter more than ever? In this episode of the Science of Skin podcast, board-certified dermatologists Dr. Patti Farris and Dr. Ruth Tedaldi break down how practitioners can seamlessly integrate medical-grade skincare into cosmetic consultations, streamline office workflows, and empower staff to become confident skincare educators. The conversation goes beyond the basics, diving into how to evaluate and select the right skincare products, why science-backed knowledge is the foundation of effective recommendations, and how a longevity-focused mindset is reshaping the future of skin health. Dr. Farris and Dr. Tedaldi also explore one of the most talked-about breakthroughs in aesthetic dermatology — exosomes — unpacking the clinical science behind their growing role in skincare treatments and the results practitioners are seeing firsthand. They spotlight innovations in hair restoration, including the science behind Rion's hair serum, and take an honest look at the rise of digital sales platforms in the professional skincare space, including their own venture, Regimen Pro. Whether you're a dermatologist, aesthetician, or skincare professional looking to elevate your practice and better serve your patients, this episode delivers the clinical insights and practical strategies you need to stay ahead. Topics covered: medical-grade skincare, aesthetic dermatology, cosmetic consultations, skincare education, exosomes, hair restoration, longevity skincare, Regimen Pro, professional skincare recommendations, office workflow optimization Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Why Do Dermatologists Love Cetaphil? The History, Science & New Reformulations Explained 10.03.2026 20p

  In this episode of the Science of Skin podcast, Dr. Patti Farris and Dr. Ted Lain explore the history and significance of Cetaphil, a legendary brand in dermatology. They discuss the origins of its key ingredient, cetal alcohol, and its role in skincare formulations, particularly for sensitive skin. The conversation highlights the brand's evolution, including recent reformulations that enhance its effectiveness while addressing modern skincare needs. The hosts emphasize the importance of barrier function and the impact of inflammation on skin health, particularly for patients with sensitive skin. They also preview future discussions on the science behind Cetaphil products. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.
• Can Skincare Reverse Aging? Inside Epigenetics with Dr. Elke Grönniger  03.03.2026 27p

  In this episode of The Science of Skin, Dr. Elke Grönniger  from Beiersdorf discusses her research on epigenetics and cellular rejuvenation, focusing on dehydromyricetin's role in demethylating the epigenome. The conversation highlights the shift towards preventative skincare, targeting the root causes of aging, and the importance of understanding the hallmarks of aging for future product development.   Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.